Nicotinamide Riboside Alleviates Corneal and Somatic Hypersensitivity Induced by Paclitaxel in Male Rats-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nicotinamide Riboside Alleviates Corneal and Somatic Hypersensitivity Induced by Paclitaxel in Male Rats

Published:2022-01-27 Issue:1 Volume:63 Page:38
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Hamity Marta V.¹,Kolker Sandra J.¹,Hegarty Deborah M.²,Blum Christopher¹,Langmack Lucy¹,Aicher Sue A.²,Hammond Donna L.¹³

Affiliation:

1. Department of Anesthesia, University of Iowa, Iowa City, Iowa, United States

2. Department of Chemical Physiology and Biochemistry, Oregon Health & Science University, Portland, Oregon, United States

3. Department of Neuroscience and Pharmacology, University of Iowa, Iowa City, Iowa, United States

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Reference52 articles.

1. TFOS DEWS II epidemiology report;Stapleton;Ocul Surf,2017

2. Burning eye syndrome: do neuropathic pain mechanisms underlie chronic dry eye?;Kalangara;Pain Med,2016

3. Ocular surface pain: a narrative review;Mehra;Ophthalmol Ther,2020

4. The role of corneal afferent neurons in regulating tears under normal and dry eye conditions;Meng;Exp Eye Res,2013

5. TFOS DEWS II pain and sensation report;Belmonte;Ocul Surf,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dry eye disease adverse reaction of pharmacological treatment for early-stage breast cancer;The Ocular Surface;2024-10

2. Nicotinamide Riboside, a Promising Vitamin B3 Derivative for Healthy Aging and Longevity: Current Research and Perspectives;Molecules;2023-08-15

3. NAD+ metabolism and eye diseases: current status and future directions;Molecular Biology Reports;2023-08-04

4. Tear film substance P in patients treated with neurotoxic chemotherapy;Experimental Eye Research;2022-11

5. Current and Emerging Pharmacotherapeutic Interventions for the Treatment of Peripheral Nerve Disorders;Pharmaceuticals;2022-05-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3